Pacira BioSciences
PCRX
PCRX
185 hedge funds and large institutions have $1.91B invested in Pacira BioSciences in 2017 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 76 increasing their positions, 52 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 180 → 185 (+5)
5.17% less ownership
Funds ownership: 108.44% → 103.26% (-5.2%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
185
Holding in Top 10
5
Calls
$26.7M
Puts
$14.8M
Top Buyers
| 1 | +$24.6M | |
| 2 | +$17.4M | |
| 3 | +$14.3M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$10.1M |
| 5 |
HM
HealthCor Management
New York
|
+$10.1M |
Top Sellers
| 1 | -$30.6M | |
| 2 | -$26.7M | |
| 3 | -$21.1M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$18M |
| 5 |
SI
Standard Investments
New York
|
-$15M |